enlicitide   Click here for help

GtoPdb Ligand ID: 13944

Synonyms: Lipfendra® | MK-0616 | MK0616
Approved drug
enlicitide is an approved drug
Compound class: Peptide
Comment: Enlicitide (MK-0616) is a macrocyclic peptide oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor [3]. PCSK9 is a dyslipidemia drug target. Enlicitide binds to PCSK9 and prevents its protein-protein interaction with the low-density lipoprotein receptor, which ultimately reduces plasma LDL-C concentration. Formulated as the chloride salt or decanoate adduct [7] for clinical use. The core peptide sequence is cyclo-Ala-D-Ala-Phe-Trp-Pro-Thr-Tyr-Pro-NH, which is formulated as as the decanoate ester to allow once-daily oral administration.
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1C(=O)N[C@H](CNC(=O)CCCCC[N+](C)(C)C)C(=O)N[C@H]2CC3=CC=CC(=C3)CNC(=O)CO[C@H]4CCN5[C@@H]4C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC6=CC=C(C=C6)OC)C(=O)N7CCC[C@@]7(C)C(=O)NCCC8=CC=C(C=C8)CN(CCCCCCN9C=C(C[C@@H](C5=O)NC2=O)C%10=C9C=CC(=C%10)F)C(=O)CCC(=O)N1
Isomeric SMILES C[C@H]1C(=O)N[C@@H](C(=O)N[C@H]2CC3=CC(=CC=C3)CNC(=O)CO[C@H]4CCN5[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N6CCC[C@]6(C(=O)NCCC7=CC=C(CN(CCCCCCN8C=C(C[C@@H](C5=O)NC2=O)C9=C8C=CC(=C9)F)C(=O)CCC(=O)N1)C=C7)C)CC%10=CC=C(C=C%10)OC)[C@@H](C)O)CNC(=O)CCCCC[N+](C)(C)C
InChI InChI=1S/C82H109FN14O15/c1-51-74(103)91-65(47-86-68(99)19-11-10-14-40-97(4,5)6)76(105)88-62-43-56-17-15-18-57(41-56)46-85-70(101)50-112-67-33-39-95-73(67)78(107)92-72(52(2)98)77(106)90-63(42-54-24-27-60(111-7)28-25-54)80(109)96-38-16-34-82(96,3)81(110)84-35-32-53-20-22-55(23-21-53)48-94(71(102)31-30-69(100)87-51)37-13-9-8-12-36-93-49-58(44-64(79(95)108)89-75(62)104)61-45-59(83)26-29-66(61)93/h15,17-18,20-29,41,45,49,51-52,62-65,67,72-73,98H,8-14,16,19,30-40,42-44,46-48,50H2,1-7H3,(H8-,84,85,86,87,88,89,90,91,92,99,100,101,103,104,105,106,107,110)/p+1/t51-,52+,62-,63-,64-,65+,67-,72-,73-,82-/m0/s1
InChI Key ZJMSWDDEBKNMLX-HMPNVHCESA-O

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Classification Click here for help
Compound class Peptide
Approved drug? Yes. US FDA (2026)
International Nonproprietary Names Click here for help
INN number INN
12515 enlicitide chloride
Synonyms Click here for help
Lipfendra® | MK-0616 | MK0616
Database Links Click here for help
CAS Registry No. 2407527-14-2 (source: PubChem)
GtoPdb PubChem SID 513757629
PubChem CID 164933665
Search Google for chemical match using the InChIKey ZJMSWDDEBKNMLX-HMPNVHCESA-O
Search Google for chemicals with the same backbone ZJMSWDDEBKNMLX
Search PubMed clinical trials enlicitide chloride
Search PubMed titles enlicitide chloride
Search PubMed titles/abstracts enlicitide chloride
UniChem Compound Search for chemical match using the InChIKey ZJMSWDDEBKNMLX-HMPNVHCESA-O
UniChem Connectivity Search for chemical match using the InChIKey ZJMSWDDEBKNMLX-HMPNVHCESA-O